Competition: Antitrust, UCL and Privacy (CLA)
- Publisher:
- California Lawyers Association
- Publication date:
- 2023-07-02
Issue Number
- No. 33-1, March 2023
- No. 32-2, September 2022
- No. 32-1, March 2022
- No. 31-2, September 2021
- No. 31-1, March 2021
- No. 30-2, September 2020
- No. 30-1, March 2020
- No. 29-2, September 2019
- No. 29-1, March 2019
- No. 27-1, December 2018
- No. 28-1, September 2018
- No. 26-1, March 2017
- No. 25-2, September 2016
- No. 25-1, March 2016
- No. 24-2, September 2015
- No. 24-1, March 2015
- No. 23-2, September 2014
- No. 23-1, March 2014
Latest documents
- Restrictions on Worker Mobility and the Need for Stronger Policies on Anticompetitive Employment Contract Provisions
- Dormant Commerce Clause: a Potential Brake on State Antitrust Legislation
- Over-prescription Is Bad Medicine: the Case Against a Knee-jerk Revision of Antitrust Injury
- California Should Amend the Cartwright Act to Address Single-firm Monopolization
- Message from the Advisors
- Should California Adopt Revisions Proposed by Congress and the New York State Legislature to Address Single-firm Conduct?
- Technological Monopolies, Innovation, and the Personal Freedom to Form Businesses: Like Oil and Water?
- Why Has California Waited So Long to Enact Its Own Merger Review Law?
- The Adaptable Antitrust Laws
- Table of Contents
Featured documents
- Managing Antitrust and Complex Business Trials-a View from the Bench
- Diversity and Inclusion in the Legal Profession: a Missed Opportunity for the Antitrust Practice
- Chair's Column
- Keynote Address: a Conversation With Justice Ming W. Chin
- "all Natural" Class Actions: a Plaintiff Perspective
- The Road to Acquittal: Takeaways from U.s. v. Usher, Et Al.
- A Practitioner's Perspective: Why the Supreme Court Should Not Overturn Illinois Brick in Apple v. Pepper
- The Price of Free
- Editor's Notes
- What Past Agency Actions Say About Complexity in Merger Remedies, With an Application to Generic Drug Divestitures